Rontalizumab
Product Specifications
CAS Number
948570-30-7
Target
COX
Related Pathways
Neuroscience, Immunology/Inflammation
Purity
0.9773
Bioactivity
Rontalizumab (RhuMab IFNalpha) is a humanized monoclonal antibody that neutralizes IFNalpha, used in the study of systemic lupus erythematosus and other neurological disorders.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1202595-01 0.02 mg (E-Coli)
Recombinant Shewanella sp. Probable Fe (2+)-trafficking protein
Sign In for Pricing
View Details MBS1202595-02 0.1 mg (E-Coli)
Recombinant Shewanella sp. Probable Fe (2+)-trafficking protein
Sign In for Pricing
View Details MBS1202595-03 0.02 mg (Yeast)
Recombinant Shewanella sp. Probable Fe (2+)-trafficking protein
Sign In for Pricing
View Details MBS1202595-04 0.1 mg (Yeast)
Recombinant Shewanella sp. Probable Fe (2+)-trafficking protein
Sign In for Pricing
View Details MBS1202595-05 0.02 mg (Baculovirus)
Recombinant Shewanella sp. Probable Fe (2+)-trafficking protein
Sign In for Pricing
View Details